TY - JOUR
T1 - Depolymerizable Poly(O-vinyl carbamate-alt-sulfones) as Customizable Macromolecular Scaffolds for Mucosal Drug Delivery
AU - Kumar, Kaushlendra
AU - Castaño, Eduard Jimenez
AU - Weidner, Andrew R.
AU - Yildirim, Adem
AU - Goodwin, Andrew P.
N1 - Funding Information:
This work was supported by NIH Grants DP2EB020401 and R21EB020911. The authors thank Prof. Jennifer Cha for helpful discussions and Dr. Joseph Dragavon of the CU Biofrontiers Advanced Microscopy Core for help with FRAP experiments. Laser scanning confocal microscopy for FRAP imaging was performed on a Nikon A1R microscope acquired by the generous support of the NIST-CU CooperativeAgreement Award Number 70NANB15H226.
Publisher Copyright:
© 2016 American Chemical Society.
PY - 2016/5/17
Y1 - 2016/5/17
N2 - Interest in stimulus responsive materials and polymers has grown over the years, having shown great promise in a diverse set of applications. For drug delivery, stimulus-responsive polymers have been shown to encapsulate therapeutics such as small molecule drugs or proteins, deliver them to specific locations in the body, and release them so that they can induce a therapeutic effect in the patient. Most hydrolytically degradable polymers are synthesized via nucleophilic, anionic, or cationic polymerization, which generally requires protection of nucleophilic or protic side chains prior to polymerization. Here, we report the synthesis of novel, alternating copolymers of sulfur dioxide and O-vinyl carbamate monomers that boast excellent functional group tolerance and pH-dependent instability. Alternating copolymers were synthesized containing pendant functionalities such as alcohol, carboxylic acid, ester, and azide without deprotection or postpolymerization modification. The copolymers were then formulated via nanoprecipitation into polymer nanoparticles capable of encapsulating small molecule dyes. The polymer nanoparticles were found to degrade rapidly at pH > 6 but were stable even in highly acidic conditions. Based on this observation, a proof-of-concept study for mucosal delivery was performed using polymer nanoparticles entrapped in a mucus model. At pH 8, the diffusion of encapsulated dye was found to be similar to free dye, while at pH 5 the diffusion coefficient was an order of magnitude lower. Cell viability was retained at 200 μg/mL particles after 24 h incubation. These polymers thus show promise as customizable scaffolds for mucosal drug delivery.
AB - Interest in stimulus responsive materials and polymers has grown over the years, having shown great promise in a diverse set of applications. For drug delivery, stimulus-responsive polymers have been shown to encapsulate therapeutics such as small molecule drugs or proteins, deliver them to specific locations in the body, and release them so that they can induce a therapeutic effect in the patient. Most hydrolytically degradable polymers are synthesized via nucleophilic, anionic, or cationic polymerization, which generally requires protection of nucleophilic or protic side chains prior to polymerization. Here, we report the synthesis of novel, alternating copolymers of sulfur dioxide and O-vinyl carbamate monomers that boast excellent functional group tolerance and pH-dependent instability. Alternating copolymers were synthesized containing pendant functionalities such as alcohol, carboxylic acid, ester, and azide without deprotection or postpolymerization modification. The copolymers were then formulated via nanoprecipitation into polymer nanoparticles capable of encapsulating small molecule dyes. The polymer nanoparticles were found to degrade rapidly at pH > 6 but were stable even in highly acidic conditions. Based on this observation, a proof-of-concept study for mucosal delivery was performed using polymer nanoparticles entrapped in a mucus model. At pH 8, the diffusion of encapsulated dye was found to be similar to free dye, while at pH 5 the diffusion coefficient was an order of magnitude lower. Cell viability was retained at 200 μg/mL particles after 24 h incubation. These polymers thus show promise as customizable scaffolds for mucosal drug delivery.
UR - http://www.scopus.com/inward/record.url?scp=84969749505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969749505&partnerID=8YFLogxK
U2 - 10.1021/acsmacrolett.6b00219
DO - 10.1021/acsmacrolett.6b00219
M3 - Article
AN - SCOPUS:84969749505
SN - 2161-1653
VL - 5
SP - 636
EP - 640
JO - ACS Macro Letters
JF - ACS Macro Letters
IS - 5
ER -